Nicox European Patent Seals ZERVIATE Major Market Coverage t

Press ReleaseNicox European Patent Seals ZERVIATE Major Market Coverage to 2030 Patent coverage for ZERVIATE (cetirizine ophthalmic solution), 0.24% in Europe until 2030 January 5, 2022 - release

Related Keywords

Mexico , Japan , Valbonne , Provence Alpes Côd Azur , France , Paris , France General , United Kingdom , China , Canada , South Korea , Turkey , Chinese , Gavin Spencer , Enregistrement Universel , Pharma Bio , Kepler Cheuvreux Damien Choplain , States Europe , Sophia Antipolis , Sophie Baumont , Santen Pharmaceutical Co Ltd Of Japan , Head Of Corporate Development , European Patent Office , Lifesci Advisors , Eyevance Pharmaceuticals , Edison Investment Research Pooya Hemami London , Garnier Co Dylan Van Haaften Paris , Market Coverage , Euronext Paris , Eastern Europe , European Patent , Chief Business Officer , Drug Application , Ocumension Therapeutics , Southeast Asian , Samil Pharmaceutical , Laboratorios Grin , South East Asian , Mid Caps , Investment Research , Pooya Hemami , New York , Damien Choplain , Vice President , Chief Business , Corporate Development , Sci Advisors , French Autorit , Des March , Nicox , European , Patent , Deals , Erviate , Major , Market , Coverage , 030 ,